Products for Research Use Only
RegisterLogin

Navivumab

CAT: 0804-HY-P99750-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99750-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Navivumab (CT-P23) is an influenza A virus hemagglutinin HA monoclonal antibody. neutralizes H1, H2, H5, and H9 influenza A viruses by binding to the stem fusion domain in HA2[1].
CAS Number
1443004-16-7
Product Name Alternative
CT-P23
UNSPSC
12352203
Target
Influenza Virus
Type
Inhibitory Antibodies
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/navivumab.html
Purity
99.10
Solubility
10 mM in DMSO
Smiles
[Navivumab]
Molecular Weight
(146.6 kDa)
References & Citations
[1]Beigel JH. Polyclonal and monoclonal antibodies for the treatment of influenza. Curr Opin Infect Dis. 2018 Dec;31 (6) :527-534.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported

Alternative Products

CatalogName
T77094-01Navivumab
GTR18337670-01Navivumab Antibody
E55B0654Navivumab (Reference antibody)
VK515036-01Research Grade Navivumab
048491HA (Navivumab) discontinued
F1040-.1Anti-HA Antibody (Navivumab)
ICH5702-25mgNavivumab Biosimilar - Research Grade
GTR18315378HA Reference Antibody (Navivumab)
GTR18780738-01(Navivumab) Biosimilar Reference Antibody
GTR18697824-01Navivumab Human Monoclonal Antibody

Popular Products